Guidance document : patented medicines (notice of compliance) regulations.: H164-320/2021E-PDF
"This guidance document provides information regarding the administration of the PM (NOC) Regulations by the Office of Patented Medicines and Liaison (OPML) within the Office of Submissions and Intellectual Property (OSIP), Resource Management and Operations Directorate (RMOD), Health Canada. It is applicable to drugs that receive a notice of compliance (NOC), including pharmaceutical, biological, radiopharmaceutical and veterinary drugs"--page 7.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.899807&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Guidance document : patented medicines (notice of compliance) regulations. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Earlier edition | Guidance document |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Ligne directrice : règlement sur les médicaments brevetés (avis de conformité). Issued also in HTML format. "Effective date: 2021/05/11." |
| Publishing information | [Ottawa] : Health Canada = Santé Canada, 2021. ©2021 |
| Description | 1 online resource (36 pages) |
| ISBN | 9780660388816 |
| Catalogue number |
|
| Departmental catalogue number | 210095 |
| Subject terms | Patent medicines -- Canada. Pharmaceutical policy -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: